Osimertinib 80 mg in India: Brands, Availability and Sourcing Guide for Hospitals (2026)
Osimertinib has become the reference treatment for EGFR-mutated non-small cell lung cancer (NSCLC), and hospital pharmacies, oncology centres and chemists across India now field the same questions again and again: which osimertinib 80 mg brands are in the market, how do they differ, and how can a buyer confirm that stock is genuine and correctly […]
